Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis

Documenti analoghi

• Histopathological Findings of Appendix Specimens in Quiescent Ulcerative Colitis: Correlations With Clinical Outcomes in the ACCURE Trial
  di: Eva Visser, et al.
  Pubblicazione: (2026)
• Editorial: Obesity and Outcomes on Advanced Therapy in Ulcerative Colitis—The Fat of the Matter
  di: Anish J. Kuriakose Kuzhiyanjal, et al.
  Pubblicazione: (2025)
• Editorial: Real‐World Effectiveness of Mirikizumab in Ulcerative Colitis—A Valuable but Preliminary Glimpse
  di: Mark A. Ainsworth, et al.
  Pubblicazione: (2025)
• Editorial: Real‐World Effectiveness of Mirikizumab in Ulcerative Colitis—A Valuable but Preliminary Glimpse. Authors' Reply
  di: Shinichiro Shinzaki, et al.
  Pubblicazione: (2025)
• Simulated cost‐effectiveness of a novel precision‐guided dosing strategy in adult patients with Crohn's disease initiating infliximab maintenance therapy
  di: Elmar R. Alizadeh, et al.
  Pubblicazione: (2024)